DEBRIDAT ENFANT 4.8 mg/ml, granules for oral suspension in a vial bottle, 76.25 g
Active ingredients: Trimebutine
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 76.25 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEBRIDAT ENFANT 4,8 mg/ml, granulés pour suspension buvable en flacon
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 76,25 g avec mesurette graduée polyéthylène polystyrène
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60588704CIP73410483CIP133400934104831Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIMÉBUTINEgranulés | 0,7870 g · 100 g de granulés pour suspension buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.